India’s new clinical trial rules weaken safety nets for participants

The new rules promote easier clinical research in India but do little to improve safety and compensation for participants.

S Srinivasan

· Apr 04, 2019 · 02:30 pm

Bad news for patients as the government weakens the drug price regulator and meddles with price caps

A new committee has been set up to make recommendations to the National Pharmaceutical Pricing Authority and, in effect, take over its function.

S Srinivasan

· Mar 08, 2019 · 02:30 pm

Indian government may ask doctors to prescribe medicines under generic names. Is it practical?

With branded drugs making up 90% of the market, the move may end up missing the wood for the trees.

S Srinivasan

· Apr 21, 2017 · 02:30 pm

Ethical minefield: Pharma industry's gifts to doctors can be tax deductible, rules tribunal

The Income Tax Appellate Tribunal has said that such freebies are 'educational'.

S Srinivasan

· Jan 25, 2017 · 02:30 pm